Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
11 studies found for:    Open Studies | diabetes AND "Glucose Intolerance" | NIDDK
Show Display Options
Rank Status Study
1 Recruiting Cross-Sectional and Longitudinal Studies of "Pre-Diabetes" in the Pima Indians
Condition: Diabetes
Intervention:
2 Recruiting Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Conditions: Autoantibody Positive;   Non-diabetic Relatives at Risk for Type 1 Diabetes;   High Risk;   Impaired Glucose Tolerance
Intervention: Drug: Teplizumab
3 Not yet recruiting Community-based Adolescent Diabetes Prevention Program
Condition: Pre-Diabetes
Intervention: Behavioral: TEEN HEED
4 Recruiting Vitamin D and Type 2 Diabetes Study
Conditions: Prediabetes;   Type 2 Diabetes
Interventions: Dietary Supplement: Vitamin D (Cholecalciferol);   Other: Placebo
5 Not yet recruiting Healthy Living Partnerships to Prevent Diabetes in Veterans Pilot Study
Conditions: Pre-diabetes;   Obesity
Interventions: Behavioral: HELP Vets Intervention;   Behavioral: Individual Education Program
6 Recruiting CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Conditions: Abnormal Glucose Tolerance;   Type 1 Diabetes
Interventions: Drug: CTLA4-Ig (Abatacept);   Drug: Placebo
7 Recruiting Valued EpiGenetic Glycemic ImprovEments Through Weight Loss
Conditions: Obesity;   Pre-diabetes
Interventions: Behavioral: Weight Loss Group;   Behavioral: Delayed Weight Loss
8 Recruiting RISE Adult Medication Study
Conditions: Prediabetes;   Type 2 Diabetes
Interventions: Drug: Metformin;   Drug: Liraglutide;   Drug: Glargine;   Drug: Placebo
9 Recruiting Muscle Accrual and Function in Cystic Fibrosis-Impact of Glucose Intolerance
Condition: Cystic Fibrosis
Intervention:
10 Recruiting Effect of Dietary Habits on Metabolic Health
Conditions: Overweight;   Obesity;   Prediabetes;   Meals
Intervention: Behavioral: Meal schedule
11 Not yet recruiting Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM
Condition: Type 2 Diabetes
Interventions: Drug: Glimepiride;   Drug: Sitagliptin;   Drug: Metformin

Study has passed its completion date and status has not been verified in more than two years.